New study tests two-step surgery to delay menopause while cutting ovarian cancer risk
NCT ID NCT01907789
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at three approaches to prevent ovarian cancer in women with BRCA1 or BRCA2 gene mutations: regular screening, removing both fallopian tubes and ovaries at once, or removing only the fallopian tubes first and the ovaries later. The two-step surgery aims to delay menopause and its side effects. About 80 premenopausal women aged 30-47 are taking part to see how many complete the delayed ovary removal and whether the fallopian tube removal alone lowers cancer risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NorthShore University Health System
Evanston, Illinois, 60201, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital therapy aims to tame the fear that haunts cancer survivors
- New PET tracer could spot cancers that standard scans overlook
- Can a mesh shield ovarian cancer patients from painful hernias?
- Two-Drug combo targets Hard-to-Treat ovarian cancer
- Can Mind-Body techniques and drugs ease stress during ovarian cancer surgery?
- Gene therapy safety check: 400 cancer patients monitored for years